The OX40-OX40L Co-Stimulatory Pathway as a Shared Driver of Immune Persistence in Skin and Airway Inflammation

Francisco José Navarro-Triviño, Tiago Torres, Ricardo Ruiz-Villaverde, José Luis Moreno-Amador, Pedro Mendes-Bastos · 2026

Read The OX40-OX40L Co-Stimulatory Pathway as a Shared Driver of Immune Persistence in Skin and Airway Inflammation by Francisco José Navarro-Triviño, Tiago Torres, Ricardo Ruiz-Villaverde, José Luis Moreno-Amador, Pedro Mendes-Bastos (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13400578.txt.

Description

Francisco José Navarro-Triviño and colleagues review, in 2026, a signaling pair called OX40 and OX40L that helps T cells persist in inflamed skin and airways. The pathway was long tied to type 2 inflammation, the kind behind allergy. New work widens its role across both tissues.

Acting late in T cell activation, OX40 keeps effector cells alive, builds tissue-resident memory and tunes regulatory cells. Alarm signals from surface tissue switch on its partner on presenting cells, reinforcing allergic-type responses. The axis feeds chronic disease in eczema, asthma, rhinitis and nasal polyps, and also appears in other immune patterns and disorders. Antibody drugs targeting the pathway are discussed as a shared treatment angle.

Catalog record

CREATORFrancisco José Navarro-Triviño, Tiago Torres, Ricardo Ruiz-Villaverde, José Luis Moreno-Amador, Pedro Mendes-Bastos
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE66697
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13400578

Browse the full library · About the Tower of Babel